Cancerous Cell Growth Inhibiting Compounds
US-2017342047-A1 · Nov 30, 2017 · US
US10550095B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10550095-B2 |
| Application number | US-201715482302-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 7, 2017 |
| Priority date | Apr 7, 2016 |
| Publication date | Feb 4, 2020 |
| Grant date | Feb 4, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a compound of Formula I, II or III or a salt or prodrug or derivative thereof that is useful for skin-whitening by inhibiting melanin formation and removing existing melanin and the inhibition of melanoma growth and/or the removal of existing melanoma cells.
Opening claim text (preview).
The invention claimed is: 1. A cancerous cell growth inhibiting compound having the following formula: 2. A method of inhibiting cancerous cell growth, said method comprising the step of administering an effective amount of a compound having the following structure:
Oxygen or sulfur atoms · CPC title
with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring · CPC title
Benzopyrazoles; Hydrogenated benzopyrazoles · CPC title
Radicals substituted by oxygen atoms · CPC title
having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.